To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Impact of Obesity on the … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3.

Journal article
Authors Åsa Alsiö
Karolina Rembeck
Galia Askarieh
Peer Brehm Christensen
Martti Färkkilä
Nina Langeland
Mads Rauning Buhl
Court Pedersen
Kristine Mørch
Bart L Haagmans
Salmir Nasic
Johan Westin
Kristoffer Hellstrand
Gunnar Norkrans
Martin Lagging
Published in PloS one
Volume 7
Issue 5
Pages e37521
ISSN 1932-6203
Publication year 2012
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages e37521
Language en
Subject categories Microbiology in the medical area, Clinical virology, Infectious Medicine


Having a body mass index above or equal to 30 kg/m(2) in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to treatment with interferon and ribavirin, but details regarding the mechanisms whereby obesity reduces the efficacy of therapy remain unclear.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?